Tecnetium (99m Tc) fanolesomab | Interleukin Related interleukin-related.com

Product Name :
Tecnetium (99m Tc) fanolesomab

Search keywords :
CD15

drugId :
null

Target Vo:
3-fucosyl-N-acetyl-lactosamine

Target Vo Short Name :
CD15

Moa_Name:
Anti-CD15

First Approval Country :
United States

First Approval Date Filter:
2004

Origin Company_Name :
Palatin Technologies Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Appendicitis

Termination Status :

China Termination Status :

Highest Status:
Withdrawn

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FOXO3 Rabbit mAb MedChemExpress
JunB Rabbit mAb Cancer
Substance P Antibody: Substance P Antibody is an unconjugated, approximately 1.4/13 kDa, rabbit-derived, anti-Substance P polyclonal antibody. Substance P Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, guinea pig, and predicted: pig, cow, horse, rabbit, sheep background without labeling.

Author: Interleukin Related

Related Posts